Science Explorer Interactive view Map
Company · Salt Lake City · United States

Arrien Pharmaceuticals (United States)

arrienpharma.comROR OpenAlex
Research works
77
▲ 44% vs 2013–17
Citations
4.2k
55.2 per fractional work
Top-10% rate
21.6%
record average 16.5%
Open access
28%
world 28%

Not ranked overall: Arrien Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.56× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.25× its world share, 3 worksBiochemistry, Geneti…Neuroscience: 4.57× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.34× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.47× its world share, 0 worksChemistryComputer Science: 1.08× its world share, 1 worksComputer ScienceMaterials Science: 0.11× its world share, 0 worksMaterials ScienceMathematics: 0.17× its world share, 0 worksMathematicsMedicine: 1.76× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.2×. Every wedge is a field page.

Who are the top researchers at Arrien Pharmaceuticals (United States)?

Ranked on the composite score, Edward F. Nemeth lead among researchers whose main affiliation is Arrien Pharmaceuticals (United States).

  1. 1 Edward F. Nemeth United States · #680,729 worldwide 105 citations · 23 works
All ranked researchers at Arrien Pharmaceuticals (United States)

Which keywords describe research at Arrien Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Parathyroid Hormone, Chronic Kidney Disease, FGF23, phosphate, Cancer, Cancer Therapy, Cell Signaling and Breast Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Parathyroid Hormone8▲ 108×3 topics
  2. Chronic Kidney Disease7▲ 36×2 topics
  3. FGF237▲ 237×1 topic
  4. phosphate7▲ 237×1 topic
  5. Cancer6▲ 5.8×28 topics
  6. Inflammation5▲ 3.0×21 topics
  7. Cancer Therapy5▲ 11×9 topics
  8. Cell Signaling5▲ 20×7 topics
  9. Breast Cancer5▲ 22×4 topics
  10. Ion Channels4▲ 25×2 topics
  11. Cardiovascular Disease4▲ 4.7×4 topics
  12. Neuronal Circuits4▲ 26×2 topics
  13. Oxidative Stress4▲ 2.7×15 topics
  14. Calcium Channels4▲ 65×1 topic
  15. Voltage-Gated Channels4▲ 65×1 topic
  16. Ion Channel4▲ 115×2 topics
  17. Neurological Disorders3▲ 6.4×4 topics
  18. Synaptic Plasticity3▲ 14×2 topics
  19. GABAergic3▲ 30×1 topic
  20. Neurotransmission3▲ 30×1 topic
  21. Prostate Cancer3▲ 27×3 topics
  22. Cancer Treatment3▲ 15×2 topics
  23. Clinical Practice Guidelines3▲ 6.9×2 topics
  24. Bisphosphonates3▲ 97×1 topic
  25. Gene Expression3▲ 6.1×7 topics
  26. Osteonecrosis of the Jaw3▲ 97×1 topic
  27. Immune System3▲ 10×3 topics
  28. Metabolic Syndrome3▲ 3.9×5 topics
  29. Transcriptional Regulation3▲ 14×5 topics
  30. Calcium Signaling2▲ 25×2 topics
  31. Insulin Signaling2▲ 25×3 topics
  32. Diabetes2▲ 6.0×3 topics
  33. Nutrition2▲ 7.0×2 topics
  34. Magnesium2▲ 241×1 topic
  35. TRPM72▲ 241×1 topic
  36. Tumor Suppression2▲ 25×3 topics
  37. Epigenetic Regulation2▲ 13×4 topics
  38. Cell Migration2▲ 31×2 topics
  39. Protein Kinases2▲ 88×1 topic
  40. Ras Signaling2▲ 88×1 topic

Which research topics does Arrien Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Advanced Breast Cancer Therapies, Computational Drug Discovery Methods, Single-cell and spatial transcriptomics and Cell Image Analysis Techniques.

Advanced Breast Cancer T…1Advanced Breast Cancer Therapies: 1 fractional worksComputational Drug Discovery Methods: 1 fractional worksSingle-cell and spatial transcriptomics: 0 fractional worksCell Image Analysis Techniques: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksRNA modifications and cancer: 0 fractional worksPARP inhibition in cance…0PARP inhibition in cancer therapy: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksGlutathione Transferases and Polymorphisms: 0 fractional worksBioinformatics and Genomic Networks: 0 fractional works
Pulmonary and Respiratory MedicineComputational Theory and MathematicsMolecular BiologyBiophysics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  2. 2 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  3. 3 Single-cell and spatial transcriptomics Molecular Biology 0 works
  4. 4 Cell Image Analysis Techniques Biophysics 0 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 0 works
  6. 6 RNA modifications and cancer Molecular Biology 0 works
  7. 7 PARP inhibition in cancer therapy Oncology 0 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
  9. 9 Glutathione Transferases and Polymorphisms Molecular Biology 0 works
  10. 10 Bioinformatics and Genomic Networks Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.2%not open71.8%

World: 28% of research is openly available.

with international co-authors25.6%domestic only74.4%

World: 19% is written across borders.

How has Arrien Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 44% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Salt Lake City

All research institutions in Salt Lake City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.